Regeneron (REGN)

Regeneron (REGN) Stock Price & Analysis


REGN Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$538.01 - $837.55
Previous Close$746.52
Average Volume (3M)567.62K
Market Cap
Enterprise Value$75.63B
Total Cash (Recent Filing)$8.96B
Total Debt (Recent Filing)$2.70B
Price to Earnings (P/E)20.3
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)36.81
Shares Outstanding109,710,254
10 Day Avg. Volume535,060
30 Day Avg. Volume567,621
Standard Deviation0.09
Financial Highlights & Ratios
Price to Book (P/B)3.60
Price to Sales (P/S)0.43
Price to Cash Flow (P/CF)14.80
P/FCF Ratio14.60
Enterprise Value/Market CapN/A
Enterprise Value/Revenue6.11
Enterprise Value/Gross Profit7.30
Enterprise Value/Ebitda14.87
Price Target Upside20.26% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering19



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Regeneron’s price range in the past 12 months?
Regeneron lowest stock price was $538.01 and its highest was $837.55 in the past 12 months.
    What is Regeneron’s market cap?
    Currently, no data Available
    When is Regeneron’s upcoming earnings report date?
    Regeneron’s upcoming earnings report date is Aug 03, 2023 which is in 54 days.
      How were Regeneron’s earnings last quarter?
      Regeneron released its earnings results on May 04, 2023. The company reported $10.09 earnings per share for the quarter, beating the consensus estimate of $9.52 by $0.57.
        Is Regeneron overvalued?
        According to Wall Street analysts Regeneron’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Regeneron pay dividends?
          Regeneron does not currently pay dividends.
          What is Regeneron’s EPS estimate?
          Regeneron’s EPS estimate is $10.29.
            How many shares outstanding does Regeneron have?
            Regeneron has 107,892,105 shares outstanding.
              What happened to Regeneron’s price movement after its last earnings report?
              Regeneron reported an EPS of $10.09 in its last earnings report, beating expectations of $9.52. Following the earnings report the stock price went down -6.137%.
                Which hedge fund is a major shareholder of Regeneron?
                Among the largest hedge funds holding Regeneron’s share is Dodge & Cox. It holds Regeneron’s shares valued at 2B.


                  Regeneron Stock Smart Score

                  The Regeneron stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description


                  Founded in 1988, Regeneron Pharmaceuticals, Inc. is a New York-based biotechnology company, which discovers, develops, manufactures, and commercializes medicines for the treatment of various medical conditions. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP.


                  Top 5 ETFs holding REGN

                  Market Value
                  Smart Score
                  Vanguard S&P 500 ETF
                  Invesco QQQ Trust
                  SPDR S&P 500 ETF Trust
                  SPDR S&P 500 ETF Trust CDI
                  iShares Core S&P 500 ETF
                  Up to five ETFs with an Outperform Smart Score that hold REGN. The ETFs are listed according to market value of REGN within the ETF


                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Vertex Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis